 |
|
|
31-March-2008:
Amira Pharmaceuticals today announced the appointment of two additional members to its board of directors: Dennis M. Fenton, Ph.D. and Stephen W. Kaldor, Ph.D. <more>
04-February-2008:
Amira Pharmaceuticals and GlaxoSmithKline enter global agreement for FLAP inhibitor program. Deal follows positive phase I data from novel product candidate AM103 for the oral treatment of respiratory disease <more>
|
Two years since launch; $40 million invested; four novel
compounds discovered. Download
our fact sheet for an overview of Amira. PDF
Keep pace with developments at Amira by signing up for regular email
alerts. Sign up here.
|
